Brain Tumors

Latest News

Phase 3 Study of Investigative Glioblastoma Treatment Halted

AbbVie has halted enrollment in all ongoing studies of depatuxizumab mafodotin, after an Independent Data Monitoring Committee (IDMC) recommended a phase 3 study of the treatment be stopped due to a lack of survival benefit.

Lifetime Risk for Brain Metastasis Increased in Elderly With Some Common Cancers

Highest incidence seen for patients with non-small cell lung cancer and triple-negative breast cancer

Postoperative Stereotactic Radiosurgery Reduces Recurrence After Metastases Resection

The use of postoperative stereotactic radiosurgery could be a substitute for whole-brain radiotherapy, which has been linked to cognitive adverse effects.

Brain Tumor Histology and Incidence in Adolescents and Young Adults

Over 10 000 brain and CNS tumors are diagnosed in adolescent and young adults each year.

Electromagnetic Field Therapy Promising for Glioblastoma Treatment

Two years post-enrollment, 43% of patients in the combination therapy group were alive.

VIDEO: Global Coalition to Design Adaptive Clinical Trial for Glioblastoma

The adaptive trial design will allow GBM patients to benefit from precision medicine.

DNA From Cerebrospinal Fluid May Effectively Monitor Brain Metastases

Researchers found that brain tumor mutations could be detected from ctDNA in cerebrospinal fluid.

Chemoradiation for Glioblastoma Reduces Brain Volume

A reduction primarily in grey matter and expansion of the brain’s ventricles was observed.

Trends in Glioma Treatment Show Increased Survival Rates

Researchers found a decrease in use of radiation treatment after 2005.

Targeted Radiation Preserves Cognition in Brain Metastases Tx

Survival rates were similar for both methods, but targeted radiation helped preserve cognition.